Clinical experience with enteric-coated mycophenolate sodium (myfortic^®)BLOOM, Roy D; ROSTAING, Lionel.Drugs (Basel). 2006, Vol 66, issn 0012-6667, 43 p., SUP2Serial Issue

Hepatitis C virus and kidney diseaseKAMAR, Nassim; ALRIC, Laurent; IZOPET, Jacques et al.Clinics and research in hepatology and gastroenterology (Print). 2013, Vol 37, Num 4, pp 328-333, issn 2210-7401, 6 p.Article

Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysisKAMAR, Nassim; ROSTAING, Lionel; IGNACE, Sophie et al.Clinical transplantation. 2012, Vol 26, Num 3, pp 461-469, issn 0902-0063, 9 p.Article

Improvement in social functioning in kidney transplant patients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) : Three case studiesSHAH, Tariq.Drugs (Basel). 2006, Vol 66, pp 15-17, issn 0012-6667, 3 p., SUP2Article

Treatment of hepatitis C virus infection after renal transplantation : new insightsROSTAING, Lionel.Nephrology, dialysis, transplantation (Print). 2000, Vol 15, pp 74-76, issn 0931-0509, SUP8Conference Paper

Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)TUNCER, Murat.Drugs (Basel). 2006, Vol 66, pp 9-10, issn 0012-6667, 2 p., SUP2Article

Enteric-coated mycophenolate sodium (myfortic®) : An overview of current and future use in transplantationKAPLAN, Bruce.Drugs (Basel). 2006, Vol 66, pp 1-8, issn 0012-6667, 8 p., SUP2Article

Hépatite virale C et transplantation rénale = Hepatitis C virus and renale transplantationKAMAR, Nassim; ROSTAING, Lionel; ALRIC, Laurent et al.Gastroentérologie clinique et biologique. 2004, Vol 28, Num 2, pp 120-125, issn 0399-8320, 6 p.Article

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in patients with gastrointestinal side effects : Case studiesBOSWELL, Anita; SHEHATA, Magdi.Drugs (Basel). 2006, Vol 66, pp 19-22, issn 0012-6667, 4 p., SUP2Article

Resolution of severe anaemia and hypotension secondary to rectal ulcers in a renal transplant patient after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)ORTEGA, Francisco; BALTAR, José.Drugs (Basel). 2006, Vol 66, pp 23-24, issn 0012-6667, 2 p., SUP2Article

Action des inhibiteurs de l'enzyme de conversion sur l'évolution de l'insuffisance rénale chronique = The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failureBERNADET-MONROZIES, Pauline; ROSTAING, Lionel; KAMAR, Nassim et al.La Presse médicale (1983). 2002, Vol 31, Num 36, pp 1714-1720, issn 0755-4982, 7 p.Article

Thymoma and solid-organ transplantationGUIBERT, Nicolas; BROUCHET, Laurent; ROUQUETTE, Isabelle et al.Lung cancer. 2012, Vol 77, Num 1, pp 232-234, issn 0169-5002, 3 p.Article

Genetic heterogeneity of the NS5A gene of hepatitis C virus and early response to interferon-αBOULESTIN, Anne; SANDRES-SAUNE, Karine; PAYEN, Jean-Louis et al.The Journal of infectious diseases. 2003, Vol 188, Num 9, pp 1367-1370, issn 0022-1899, 4 p.Article

Transplantation rénale : Résultats et indications : Insuffisance rénale chronique = Renal transplantation : Chronic renal insufficiencyDURAND, Dominique; ROSTAING, Lionel; ABBAL, Michel et al.La Revue du praticien (Paris). 2001, Vol 51, Num 4, pp 404-409, issn 0035-2640Article

Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French surveySAUNE, Karine; KAMAR, Nassim; MIEDOUGE, Marcel et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 7, pp 2309-2316, issn 0931-0509, 8 p.Article

Complete resolution of severe diarrhoea after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient at high immunological riskBREIDENBACH, Thomas; SPANGENBERG, Marcus; NAGEL, Eckhard et al.Drugs (Basel). 2006, Vol 66, pp 25-27, issn 0012-6667, 3 p., SUP2Article

Ribavirin pharmacokinetics in renal and liver transplant patients: Evidence that it depends on renal functionKAMAR, Nassim; CHATELUT, Etienne; MANOLIS, Efthymios et al.American journal of kidney diseases. 2004, Vol 43, Num 1, pp 140-146, issn 0272-6386, 7 p.Article

Place de la transplantectomie après échec de greffe rénale = Kidney nephrectomy after allograft failureDEL BELLO, Arnaud; ROSTAING, Lionel; CONGY-JOLIVET, Nicolas et al.Néphrologie & thérapeutique. 2013, Vol 9, Num 4, pp 189-194, issn 1769-7255, 6 p.Article

Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipientsWOILLARD, Jean-Baptiste; KAMAR, Nassim; ROUSSEAU, Annick et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 10, pp 725-732, issn 1744-6872, 8 p.Article

CYP3A5 Genotype Does Not Influence Everolimus In Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant RecipientsPICARD, Nicolas; ROUGUIEG-MALKI, Koukeb; KAMAR, Nassim et al.Transplantation. 2011, Vol 91, Num 6, pp 652-656, issn 0041-1337, 5 p.Article

Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patientsMIEDOUGE, Marcel; SAUNE, Karine; KAMAR, Nassim et al.Journal of clinical virology. 2010, Vol 48, Num 1, pp 18-21, issn 1386-6532, 4 p.Article

Amantadine therapy in renal transplant patients with hepatitis C virus infectionKAMAR, Nassim; ROSTAING, Lionel; SANDRES-SAUNE, Karine et al.Journal of clinical virology. 2004, Vol 30, Num 1, pp 110-114, issn 1386-6532, 5 p.Article

Ribavirin for Chronic Hepatitis E Virus Infection in Transplant RecipientsKAMAR, Nassim; IZOPET, Jacques; BUCHLER, Matthias et al.The New England journal of medicine. 2014, Vol 370, Num 12, pp 1111-1120, issn 0028-4793, 10 p.Article

A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipientsKAMAR, Nassim; ROSTAING, Lionel; DI GIAMBATTISTA, Fabienne et al.Clinical nephrology. 2012, Vol 77, Num 2, pp 126-136, issn 0301-0430, 11 p.Article

Assessing Renal Function With Daclizumab Induction and Delayed Tacrolimus Introduction in Liver Transplant RecipientsCALMUS, Yvon; KAMAR, Nassim; CHAZOUILLERES, Olivier et al.Transplantation. 2010, Vol 89, Num 12, pp 1504-1510, issn 0041-1337, 7 p.Article